Skip to main content
NCBI home page
Acta Pharmacologica Sinica logoLink to Acta Pharmacologica Sinica
. 2014 Apr 21;35(6):707–715. doi: 10.1038/aps.2013.197

Hydrogen sulfide inhibits homocysteine-induced endoplasmic reticulum stress and neuronal apoptosis in rat hippocampus via upregulation of the BDNF-TrkB pathway

Hai-jun Wei 1,#, Jin-hua Xu 2,#, Man-hong Li 1,3, Ji-ping Tang 1,3, Wei Zou 3, Ping Zhang 3,*, Li Wang 4, Chun-yan Wang 5, Xiao-qing Tang 1,*
PMCID: PMC4086382  PMID: 24747165

Abstract

Aim:

Homocysteine (Hcy) can elicit neuronal cell death, and hyperhomocysteinemia is a strong independent risk factor for Alzheimer's disease. The aim of this study was to examine the effects of hydrogen sulfide (H2S) on Hcy-induced endoplasmic reticulum (ER) stress and neuronal apoptosis in rat hippocampus.

Methods:

Adult male SD rats were intracerebroventricularly (icv) injected with Hcy (0.6 μmol/d) for 7 d. Before Hcy injection, the rats were treated with NaHS (30 or 100 μmol·kg−1·d−1, ip) and/or k252a (1 μg/d, icv) for 2 d. The apoptotic neurons were detected in hippocampal coronal slices with TUNEL staining. The expression of glucose regulated protein 78 (GRP78), C/EBP homologous protein (CHOP), cleaved caspase-12, and BDNF in the hippocampus were examined using Western blotting assays. The generation of H2S in the hippocampus was measured with the NNDPD method.

Results:

Hcy markedly inhibited the production of endogenous H2S and increased apoptotic neurons in the hippocampus. Furthermore, Hcy induced ER stress responses in the hippocampus, as indicated by the upregulation of GRP78, CHOP, and cleaved caspase-12. Treatment with the H2S donor NaHS increased the endogenous H2S production and BDNF expression in a dose-dependent manner, and significantly reduced Hcy-induced neuronal apoptosis and ER stress responses in the hippocampus. Treatment with k252a, a specific inhibitor of TrkB (the receptor of BDNF), abolished the protective effects of NaHS against Hcy-induced ER stress in the hippocampus.

Conclusion:

H2S attenuates ER stress and neuronal apoptosis in the hippocampus of Hcy-treated rats via upregulating the BDNF-TrkB pathway.

Keywords: hydrogen sulfide, homocysteine, neurotoxicity, hippocampus, apoptosis, ER stress, BDNF, tyrosine protein kinase B, Alzheimer's disease

Introduction

Homocysteine (Hcy) is a sulfur-containing amino acid generated during methionine metabolism1,2. Hcy can elicit neuronal cell death in a variety of neuronal types including hippocampal and cortical neurons3,4,5, Purkinje cells6, cerebellar granule cells7, and the human neuroblastoma cell line SH-SY5Y8,9. Increasingly, epidemiologic studies have established that elevated level of circulating Hcy, namely hyperhomocysteinemia, is a strong independent risk factor for Alzheimer's disease (AD)10,11,12,13,14.

Emerging evidence indicates that endoplasmic reticulum (ER) stress plays a pivotal role in the development or pathology of AD, which is characterized by an abnormal formation of inclusion bodies and aggregation of misfolded proteins15,16,17. The ER is a sophisticated luminal network for the synthesis, maturation, folding, and transportation of proteins, which are required for cell survival and normal cellular functions18,19. Disturbance of protein folding under various physiological or pathological conditions, such as alteration of cellular redox, deprivation of glucose, aberration of Ca2+ regulation, and viral infections, creates the ER stress20. Wei et al reported that exposure to Hcy of the rat embryonic heart-derived cell line H9c2 can increase the expression of ER stress response genes, such as glucose regulated protein 78 (GRP78), C/EBP homologous protein (CHOP), and cleaved caspase-1221, suggesting that ER stress is involved in the mechanisms of Hcy-induced cellular dysfunction8,22,23,24,25. Therefore, it is logical to speculate that inhibiting Hcy-induced ER stress may be a novel therapeutic strategy to prevent and ameliorate AD progression.

Hydrogen sulfide (H2S), the third gaseous mediator, has recently been recognized as an important endogenous neuromodulator and neuroprotectant26,27,28,29. The most recent in vitro studies by our group have demonstrated that Hcy-associated neurotoxicity to PC12 cells is due to reduced endogenous generation of H2S30 and that supplementation of sodium hydrosulfide (NaHS), the H2S-donor, ameliorates the Hcy elicited-neurotoxicity in PC12 cells31. However, the mechanisms underlying the protective effect of H2S against Hcy neurotoxicity are not completely understood. Recent studies have demonstrated that H2S inhibits ER stress in apolipoprotein E knockout mice32 and in doxorubicin-treated H9c2 cells33. In addition, H2S has been shown to attenuate 6-hydroxydopamine-induced ER stress in SH-SY5Y cell line34. Furthermore, H2S could antagonize cardiomyocytic ER stress in Hcy-induced cardiomyocytic injury21.

The impact of H2S on ER stress involved in the neurotoxicity of Hcy is not yet known. Given the importance of Hcy in the pathogenesis of AD and the elevated ER stress response to Hcy, it is imperative to understand if the Hcy-induced ER stress status of neurocytes is regulated by H2S and to investigate the underlying mechanisms. Brain-derived neurotrophic factor (BDNF), a neurotrophic factor acting on the central nervous system, prevents ordinary types of neuronal cell death induced by various stimulants. Increasing evidence has demonstrated that prevention of ER stress contributes to BDNF-mediated neuroprotection35,36,37. Therefore, the present study was undertaken to examine whether H2S could regulate Hcy-induced neuronal ER stress in a rat model of Hcy neurotoxicity in vivo. Furthermore, the involvement of the BDNF-tyrosine protein kinase B (TrkB) pathway in H2S-attenuated ER stress induced by Hcy was also investigated. In this study, we demonstrated for the first time the protective effects of H2S against Hcy-induced ER stress in the hippocampus of rats and that the underlying mechanism involves the upregulation of the BDNF-TrkB pathway.

Materials and methods

Reagents

NaHS, Hcy, and k252a (an inhibitor of the BDNF receptor TrkB) were purchased from Sigma-Aldrich (St Louis, MO, USA). The in situ apoptosis detection kit was supplied by Roche Diagnostics (Indianapolis, IN, USA). Specific monoclonal anti-BDNF, anti-GRP78, and anti-CHOP antibodies were purchased from Epitomics Inc (Burlingame, CA, USA). Specific monoclonal anti-caspase-12 antibody was obtained from Sigma-Aldrich. RPMI-1640 medium, horse serum, and fetal bovine serum (FBS) were supplied by Gibco BRL (Grand Island, NY, USA).

Cell culture

PC12 cells, originally derived from a transplantable rat pheochromocytoma, were supplied by Sun Yat-sen University Experimental Animal Center (Guangzhou, China) and maintained on tissue culture plastic in RPMI-1640 medium supplemented with 10% heat-inactivated horse serum and 5% FBS at 37 °C under an atmosphere of 5% CO2 and 95% air. The culture medium was changed three times per week.

Animals

Adult male Sprague-Dawley rats (250–280 g), obtained from the SJA Lab Animal Center of Changsha (Changsha, China), were housed individually in a temperature- and humidity-controlled room and kept on a 12-h light/12-h dark cycle with free access to food and water. The rats were handled (2–3 min per rat per day) for one week to be accustomed to the experimenter. Experiments were conducted in accordance with the National Institute of Health's Guide for the Care and Use of Laboratory Animals and were approved by the Animal Use and Protection Committee of University of South China. All efforts were made to minimize animal's suffering.

Drugs and treatments

Hcy and NaHS were dissolved in 0.9% nonpyrogenic NaCl and the solution was filtered through a 0.2-μm PTFE filter (Sigma-Aldrich). K252a was dissolved in sterilized artificial cerebrospinal fluid/dimethyl sulfoxide (ACSF/DMSO; volum ratio, 1:1) (Sigma-Aldrich). Hcy and k252a were injected intracerebroventricularly (icv), and NaHS was injected intraperitoneally (ip). Rats were divided into four treatment groups: 1) a control group, in which subjects were treated with saline (ip) and ACSF/DMSO (icv) every day for 9 d; 2) an Hcy-treated alone group, in which subjects were treated with 0.6 μmol/d Hcy (icv) for 7 d; 3) a co-treated with Hcy and NaHS group, in which subjects were pretreated with 30 or 100 μmol·kg−1·d−1 NaHS (ip) for 2 d and then co-treated with 0.6 μmol/d Hcy (icv) for 7 d; and 4) a k252a-inhibition group, in which subjects were pretreated with 30 or 100 μmol/kg NaHS (ip) and 1 μg/d k252a (icv) for 2 d and then co-treated with 0.6 μmol Hcy (icv) per day for 7 d. The intraperitoneal treatments were administered in a volume of 1 mL/kg body weight. The intracerebroventricular treatments were administered in a volume of 2.5 μL.

Intracerebroventricular injection

The rats were anesthetized with sodium pentobarbital (45 mg/kg, ip) and placed into a stereotaxic apparatus for operation. Saline, ACSF/DMSO, Hcy (0.6 μmol), or k252a (1μg) with a volume of 2.5 μL was injected into the bilateral ventricle at the following coordinates: anterior/posterior −1.4 mm, medial/lateral 1.8 mm, dorsal/ventral −3.0 mm from the bregma, respectively, with an injection rate of 0.5 μL/min under the control of a micropump. To ensure that the entire injection had been delivered, the injection cannula was allowed to remain in place for an additional minute before being removed.

TdT-mediated dUTP nick-end labeling (TUNEL) staining

After anesthesia, rats were fixed by perfusing 200–300 mL of Zamboni's fixative (4% paraformaldehyde in 0.1 mol/L phosphate buffer, pH=7.4) through the left ventricle of the heart. The hippocampus was removed and post-fixed in the perfusion fixative for 2 h at room temperature and then immersed in a 20% sucrose solution until the tissue sank. The hippocampus was coronally sectioned with a cryostat at a thickness of 10 μm.

To detect the apoptotic cell death in the hippocampus, we processed the sections of the hippocampus for TUNEL staining using an in situ apoptosis detection kit (Roche Diagnostics). Briefly, sections were digested with 15 μg/mL proteinase K for 15 min at room temperature and then washed with phosphate buffered saline (PBS). Endogenous peroxidase activity was quenched with 3% H2O2 for 5 min at room temperature. After being washed with PBS, the sections were immersed in terminal deoxynucleotidyl transferase (TdT) labeling buffer, covered with TdT buffer containing TdT, 1 mmol/L Mn2+, and biotinylated dNTP, and incubated in a humid atmosphere at 37 °C for 90 min before being washed with PBS. The sections were then incubated with streptavidin-horseradish peroxidase for 30 min. The sections were rinsed with PBS, and immersed in diaminobenzidine solution. The slides were counterstained for 1 min with 1% methyl green. The total number of TUNEL-positive cells on each section was counted under a microscope. The data are presented as the number of positive neurons/mm2.

Assay of H2S generation

The hippocampus was homogenized in 50 mmol/L ice-cold potassium phosphate buffer (pH 6.8). The reaction mixture contained potassium phosphate buffer (pH 7.4, 100 mmol/L), L-cysteine (20 μL, 10 mmol/L), pyridoxyal 5'-phosphate (20 μL, 2 mmol/L), saline (30 μL), and tissue homogenate (430 μL, 11% w/v). The reaction was performed in tightly stoppered cryovial test tubes and initiated by transferring the tubes from ice to a shaking water bath at 37 °C. After incubation for 30 min, zinc acetate (250 μL, 1% w/v) was added to trap evolved H2S followed by trichloroacetic acid (250 μL, 10% v/v) to denature the protein and stop the reaction. Subsequently, N,N-dimethyl-p-phenylenediamine sulfate (NNDPD; 133 μL, 20 μmol/L) in 7.2 mol/L HCl was added, immediately followed by FeCl3 (133 μL, 30 μmol/L) in 1.2 mol/L HCl. The absorbance of the resulting solution at 670 nm was measured by spectrophotometry. The H2S concentration was calculated against a calibration curve of NaHS, and H2S synthesizing activity was determined using a BCA Protein Assay Kit (Beyotime, Shanghai, China) and expressed as micromoles of H2S formed from 1 g protein per minute (nmol·min−1·mg−1 protein).

SDS-PAGE and Western blotting analysis

Hippocampal tissues were homogenized in an ice-cold lysis buffer [20 mmol/L Tris-HCl (pH 7.5), 150 mmol/L NaCl, 1% Triton X-100, 1 mmol/L phenylmethylsulfonylfluoride (PMSF), 1 mmol/L Na3VO4, leupeptin, and EDTA]. Then, the samples were centrifuged at 14 000 rounds/min for 30 min at 4 °C, and the supernatant was collected. The protein concentration was assessed using a BCA Protein Assay Kit (Beyotime). Equivalent amount of protein for each sample was run on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The protein was then transferred to a PVDF membrane and blocked in TBST buffer [50 mmol/L Tris-HCl (pH 7.5), 150 mmol/L NaCl, 0.05% Tween-20] containing 5% bovine serum albumin for 2 h. The membrane was incubated with blocking solution containing primary antibody (anti-CHOP, 1:500; anti-GRP78, 1:2000; anti-caspase-12, 1:2000; or anti-BDNF, 1:2000) overnight at 4 °C. After being washed with TBST-buffer, the membrane was incubated in anti-rabbit secondary antibody conjugated to horseradish peroxidase (1:5000) in blocking solution for 2 h. Next, the membrane was washed with TBST buffer and incubated in the electrogenerated chemiluminescence reaction solutions (solution 1: 0.1 mol/L Tris-HCl, luminol, p-coumaric acid; solution 2: 0.1 mol/L Tris-HCl, hydrogen peroxide) for 2 min. The signal of the immunoblots was visualized using an image analysis system equipped with the software BIO-ID (Vilber Lourmat, Marne-la-Vallée, France).

Statistical analysis

Data are expressed as the mean±SEM. The significance of inter-group differences was evaluated by one-way analysis of variance (ANOVA), followed by a Newman-Keuls test. Differences were considered significant at two-tailed P<0.05.

Results

H2S attenuates Hcy-induced neuronal apoptosis in the hippocampal CA1 region

We first detected the apoptotic cells in the hippocampus slices by TUNEL staining to confirm the protection of H2S against Hcy-induced neurotoxicity in vivo. As shown in Figure 1, after 7-d treatment with Hcy (0.6 μmol/d, icv), significant amounts of TUNEL-positive neurons appeared in the hippocampal CA1 region in the rats. However, the TUNEL-positive neurons in the hippocampal CA1 region were markedly decreased in the rats pretreated with NaHS (100 μmol·kg−1·d−1 for 2 d, ip) and then co-treated with Hcy (0.6 μmol/d for 7 d, icv).

Figure 1.

Figure 1

Open in a new tab

Effect of NaHS on Hcy-induced neuronal apoptosis in the hippocampal CA1 region of rats. Rats were pretreated with NaHS (100 μmol·kg−1·d−1 for 2 d, ip) and then co-treated with Hcy (0.6 mol/d for 7 d, icv), and the hippocampus was processed for TUNEL staining using an in situ apoptosis detection kit. (A) Representative images of TUNEL staining of the hippocampus in different treatment groups (100× objective, BX50-FLA, Olympus). Arrows indicate the apoptotic neurons. (B) TUNEL-positive neuron counts in the hippocampus under different treatments. Values are expressed as the mean±SEM (n=5). cP<0.01 vs non-treated control group. fP<0.01 vs Hcy-treated alone group.

H2S upregulates BDNF expression in hippocampus of rats

To explore if the upregulation of BDNF is involved in the mechanism underlying the protective effect of H2S against Hcy-elicited neurotoxicity, we investigated the effect of H2S on BDNF expression in the hippocampus of rats. BDNF expression was markedly downregulated in the hippocampus of rats treated with Hcy (0.6 μmol/d for 7 d, icv). However, BDNF expression was reversed in the hippocampus of rats pretreated with NaHS (30 and 100 μmol·kg−1·d−1 for 2 d, ip) and then co-treated with Hcy (0.6 μmol/d for 7 d, icv) (Figure 2A). In addition, the expression of BDNF was upregulated in the hippocampus of rats treated with NaHS (30 and 100 μmol·kg−1·d−1 for 9 d, ip) (Figure 2B).

Figure 2.

Figure 2

Open in a new tab

NaHS upregulates the expression of BDNF in the hippocampus of rats. (A) Rats were pretreated with NaHS (30 and 100 μmol·kg−1·d−1 for 2 d, ip) and then co-treated with Hcy (0.6 μmol/d for 7 d, icv). (B) Rats were treated with NaHS (30 and 100 μmol·kg−1·d−1 for 9 d, ip). The expression of BDNF in the hippocampus of rats was detected by Western blotting using an anti-BDNF antibody, and β-actin was used as a loading control. Values are expressed as the mean±SEM (n=3−5). cP<0.01 vs control group. fP<0.01 vs Hcy-treated alone group.

H2S decreases Hcy-induced upregulation of GRP78 expression in the hippocampus of rats, and this effect is abolished by blocking the BDNF-TrkB pathway

To investigate whether Hcy induces ER stress in the hippocampus of rats and whether H2S inhibits Hcy-induced ER stress, we first sought to explore the expression of GRP78, an important marker for ER stress, in the hippocampus of rats. As shown in Figure 3A, Hcy (0.6 μmol/d for 7 d, icv) significantly increased GRP78 expression in the hippocampus of rats. However, pretreatment with NaHS (30 and 100 μmol·kg−1·d−1 for 2 d, ip) before the co-treatment with Hcy for 7 d clearly decreased the upregulated expression of GRP78 induced by Hcy. These findings indicate the effects of Hcy on ER stress in the hippocampus and the inhibitory effect of H2S on Hcy-induced ER stress.

Figure 3.

Figure 3

Open in a new tab

NaHS decreases Hcy-upregulated GRP78 expression in the hippocampus of rats, and this effect is abolished by k252a, a specific inhibitor of the BDNF receptor TrkB. (A) Rats were pretreated with NaHS (30 and 100 μmol·kg−1·d−1 for 2 d, ip) and then co-treated with Hcy (0.6 μmol/d for 7 d, icv). (B) Rats were pretreated with NaHS (30 and 100 μmol·kg−1·d−1 for 2 d, ip) in the absence or presence of treatment with k252a (1 μg/d for 2 d, icv) and then co-treated with Hcy (0.6 μmol/d for 7 d, icv). The expression of GRP78 in the hippocampus was detected by Western blotting using an anti-GRP78 antibody, and β-actin was used as a loading control. Values are expressed as the mean±SEM (n=3−5). cP<0.01 vs control group. eP<0.05, fP<0.01 vs Hcy-treated alone group. hP<0.05 vs co-treated with Hcy and NaHS group.

To determine the involvement of the BDNF-TrkB pathway in H2S neuroprotection against Hcy-induced ER stress, we investigated the effect of k252a on the inhibitory role of H2S in Hcy-upregulated GRP78 expression. As shown in Figure 3B, treatment with k252a (1 μg/d for 9 d, icv) dramatically curbed the preventive effects of NaHS (100 μmol·kg−1·d−1 for 9 d, ip) on the expression of GRP78 in the hippocampus of rats treated with Hcy (0.6 μmol/d for 7 d, icv), indicating that the protective effect of H2S against Hcy-induced ER stress is mediated by stimulation of the BDNF-TrkB pathway.

H2S represses Hcy-induced upregulation of CHOP expression in hippocampus of rats, and this effect is blocked by inhibiting the BDNF-TrkB pathway

To further ascertain whether exposure to Hcy induces ER stress, we proceeded to monitor the CHOP protein level in the hippocampus of rats. CHOP expression in the hippocampus of rats treated with Hcy (0.6 μmol/d for 7 d, icv) was clearly increased. However, upregulated CHOP expression was attenuated in the hippocampus of rats by pretreating with NaHS (30 and 100 μmol·kg−1·d−1 for 2 d, ip) before co-treatment with Hcy (0.6 μmol/d for 7 d, icv) (Figure 4A). These data also indicated the protective action of H2S on Hcy-induced ER stress.

Figure 4.

Figure 4

Open in a new tab

NaHS suppresses Hcy-upregulated CHOP expression in the hippocampus of rats, and this effect is blocked by k252a. (A) Rats were pretreated with NaHS (30 and 100 μmol·kg−1·d−1 for 2 d, ip) and then co-treated with Hcy (0.6 μmol/d for 7 d, icv). (B) Rats were pretreated with NaHS (30 and 100 μmol·kg−1·d−1 for 2 d, ip) in the absence or presence of treatment with k252a (1 μg/d for 2 d, icv) and then co-treated with Hcy (0.6 μmol/d for 7 d, icv). The expression of CHOP in the hippocampus of rats was detected by Western blotting using an anti-CHOP antibody, and β-actin was used as a loading control. Values are expressed as the mean±SEM (n=3−5). cP<0.01 vs control group. eP<0.05, fP<0.01 vs Hcy-treated alone group. iP<0.01 vs co-treated with Hcy and NaHS group.

We also explored the effect of k252a on the suppressive role of H2S in Hcy-upregulated CHOP expression. Western blotting analysis revealed that administration of k252a (1 μg/d, icv, for 9 d) prevented NaHS (100 μmol·kg−1·d−1 for 9 d, ip) from suppressing the expression of CHOP in the hippocampus of rats treated with Hcy (0.6 μmol/d for 7 d, icv) (Figure 4B). This suggests an important role of the BDNF-TrkB pathway in mediating the neuroprotective effect of H2S against ER stress induced by Hcy.

H2S reduces Hcy-induced upregulation of cleaved caspase-12 expression in hippocampus of rats, and this effect is blocked by inhibition of the BDNF-TrkB pathway

Cleaved caspase-12 participates in ER stress-induced apoptosis. Therefore, we further investigated the expression of cleaved caspase-12 in the hippocampus of rats. As shown in Figure 5A, Hcy (0.6 μmol/d for 7 d, icv) significantly upregulated the expression of cleaved caspase-12 in the hippocampus of rats. However, pretreatment with NaHS (30 and 100 μmol·kg−1·d−1 for 2 d, ip) before co-treatment with Hcy for 7 d clearly suppressed the upregulation of cleaved caspase-12 induced by Hcy. These data suggested that H2S treatment produces a protective role in ER stress-induced apoptosis.

Figure 5.

Figure 5

Open in a new tab

NaHS suppresses Hcy-upregulated cleaved caspase-12 expression in the hippocampus of rats, and this effect is blocked by k252a. (A) Rats were pretreated with NaHS (30 and 100 μmol·kg−1·d−1 for 2 d, ip) and then co-treated with Hcy (0.6 μmol/d for 7 d, icv). (B) Rats were pretreated with NaHS (30 and 100 μmol·kg−1·d−1 for 2 d, ip) in the absence or presence of treatment with k252a (1 μg/d for 2 d, icv) and then co-treated with Hcy (0.6 μmol/d for 7 d, icv). The expression of cleaved caspase-12 in the hippocampus of rats were detected by Western blotting using an anti-cleaved caspase-12 antibody, and β-actin was used as a loading control. Values are expressed as the mean±SEM (n=3−5). bP<0.05, cP<0.01 vs control group. eP<0.05, fP<0.01 vs Hcy-treated alone group. iP<0.01 vs co-treated with Hcy and NaHS group.

We further investigated the effect of k252a on the inhibitory role of H2S in Hcy-upregulated expression of cleaved caspase-12. As shown in Figure 5B, administration of the inhibitor of the BDNF receptor k252a (1 μg/d for 9 d, icv) prevented NaHS (100 μmol·kg−1·d−1 for 9 d, ip) from inhibiting the upregulated expression of cleaved caspase-12 in the hippocampus of rats treated with Hcy (0.6 μmol/d for 7 d, icv). This suggests that the BDNF-TrkB pathway mediates the neuroprotective effect of H2S against Hcy-induced ER stress.

H2S prevents Hcy-induced ER stress in PC12 cells

To further confirm the protective effect of H2S against Hcy-induced ER stress, we investigated the effects of H2S on Hcy-induced ER stress in PC12 cells. As illustrated in Figure 6, pretreatment with NaHS (200 μmol/L) for 30 min significantly attenuated the increases in the expression levels of GRP78, CHOP, and cleaved caspase-12 in PC12 cells induced by treatment with 5 mmol/L of Hcy for 24 h. These data confirm the protective effect of H2S against Hcy-induced ER stress in vitro.

Figure 6.

Figure 6

Open in a new tab

NaHS suppresses Hcy-induced ER stress in PC12 cells. After pretreatment with NaHS (200 μmol/L) for 30 min, PC12 cells were exposed to Hcy (5 mmol/L) for 24 h. The levels of GRP78 (A), CHOP (B), and cleaved caspase-12 (C) expression in PC12 cells were detected by Western blotting using anti-GRP78, -CHOP, and -cleaved caspase-12 antibody, respectively. In all blots, staining for β-actin was used as a loading control. Values are presented as the mean±SEM (n=3). cP<0.01 vs control group. fP<0.01 vs Hcy-treated alone group.

Hcy inhibits endogenous hippocampal H2S production, which is reversed by NaHS administration

To know the feedback effect of ER stress on H2S production in the hippocampus, we explored the level of hippocampal endogenous H2S production in the rats treated with Hcy and the restorative effect of NaHS administration. As shown in Figure 7, the generation of H2S in the hippocampus of rats treated with Hcy (0.6 μmol/d for 7 d, icv) was markedly inhibited. However, the generation of H2S in the hippocampus of rats was rescued by pretreating with NaHS (30 and 100 μmol·kg−1·d−1 for 2 d, ip) before co-treatment with Hcy (0.6 μmol/d for 7 d, icv).

Figure 7.

Figure 7

Open in a new tab

Hcy inhibits hippocampal endogenous H2S generation, which is rescued by the administration of NaHS. Rats were pretreated with NaHS (30 and 100 μmol·kg−1·d−1 for 2 d, ip) and then co-treated with Hcy (0.6 μmol/d for 7 d, icv). The hippocampus of rats was homogenized and the generation of H2S in the hippocampus was measured by the NNDPD method as described in the Materials and Methods section. Values are expressed as the mean±SEM (n=3−5). cP<0.01 vs control group. fP<0.01 vs Hcy-treated alone group.

Discussion

H2S is an emerging novel endogenous neuroprotectant. We have previously demonstrated the protective effect of H2S against the neurotoxicity of Hcy. The present study was designed to investigate the role of H2S in regulating Hcy-induced neuronal ER stress and the underlying mechanisms. We showed that H2S upregulates the expression of BDNF in the hippocampus of rats and that intracerebroventricular injection of Hcy leads to an increase in the expression of various ER stress-associated proteins, including GRP78, CHOP, and cleaved caspase-12, in the hippocampus of rats. Notably, we found that H2S was able to downregulate the elevated ER stress markers. Furthermore, blocking of the BDNF-TrkB pathway by the inhibitor of TrkB, k252a, reverses the protective role of H2S in Hcy-induced ER stress. Collectively, these findings suggest that H2S could attenuate neuronal ER stress in Hcy-induced neurotoxicity by upregulating the pathway of BDNF-TrkB.

Hcy is an independent risk factor for AD10,11,12,13,14. ER stress is implicated in the development or pathology of AD15,16,17. Although it is not clear if Hcy triggers neuronal ER stress, ER stress has been proposed to explain the pathogenic effects of Hcy in cardiovascular disease21, insulin resistance of adipose tissue38, apoptosis of osteoblastic cells39, type 2 diabetes mellitus40, and hepatic steatosis41. ER stress may be a common pathway of the injury of tissues and cells induced by Hcy. In the present work, we examined the effects of Hcy on the expression of protein markers of ER stress, such as GRP78, CHOP, and cleaved caspase-12, in the hippocampus of rats. We found that expressions of GRP78, CHOP, and cleaved caspase-12 in the hippocampus of rats were all upregulated by intracerebroventricular injection of Hcy. This indicated that Hcy-induced, severe ER stress was present in the hippocampus, suggesting that ER stress is a contributory factor in Hcy-induced neurotoxicity.

Interestingly, H2S and Hcy are metabolites of methionine42, but they exert entirely opposite effects on the viability of neurocytes. Hcy induces accumulation of reactive oxygen species (ROS) and stimulates neurotoxicity43,44, whereas H2S scavenges ROS and protects neurons against oxidative stress45,46,47,48. Furthermore, both elevation of Hcy and decrease of H2S are detected in the brains of AD patients49. Therefore, we have previously explored if H2S directly antagonizes the toxicity of Hcy to neuronal cells, and our previous data revealed that H2S could attenuate the neurotoxicity of Hcy31. It has been reported that H2S serves as a protective gaseous signaling molecule in the nervous system by preserving mitochondrial function50,51. The ER is another important subcellular organelle critical for protein folding and the formation of disulfide bonds52. Investigating if H2S can affect the ER function is important for elucidating the mechanisms underlying the protective effect of H2S against Hcy-induced neurotoxicity.

In the present study, we demonstrated that administration of NaHS alleviated the expression of GRP78, CHOP, and cleaved caspase-12 in the hippocampus of rats treated intracerebroventricularly with Hcy. The fact that H2S suppresses the expression of GRP78, CHOP, and cleaved caspase-12 is consistent with its effect on the toxicity of Hcy in cardiomyocytes21. Moreover, the protective effects of H2S against Hcy-induced ER stress were further confirmed in PC12 cells. Our results indicated that H2S counteracts Hcy-induced ER stress, contributing to the role of H2S in protecting against Hcy-induced neurotoxicity.

We further examined the possible signaling mechanisms for the protective effect of H2S against Hcy-induced ER stress. BDNF, a member of the neurotrophin family, regulates the development, maintenance, plasticity, and function of the nervous system53,54. In vitro and in vivo studies indicate that BDNF functions as a neuroprotective agent and rescues neurons from various insults55,56. Increasing evidence has shown that BDNF plays an important role in counteracting ER stress35,36,37, suggesting that the suppression of ER stress may contribute to BDNF-mediated neuroprotection. The action of BDNF is mediated by its binding to the TrkB receptor. In the present study, we investigated the contribution of the BDNF-TrkB pathway to the inhibitory role of H2S in Hcy-induced ER stress. We found that NaHS upregulated the expression of BDNF in the hippocampus of rats. Furthermore, our present data demonstrated that blocking the BDNF-TrkB pathway by the inhibitor of TrkB reversed the inhibitory effect of H2S on the expression of GRP78, CHOP, and cleaved caspase-12 in the hippocampus of rats treated with Hcy. Our results suggest that H2S exerts its protective effects against Hcy-induced ER stress by upregulation of the BDNF-TrkB pathway.

In conclusion, the present observations identify the beneficial role of H2S in protecting the hippocampus against Hcy-induced ER stress. The neuroprotective effect of H2S involves the regulation of the BDNF-TrkB pathway. The findings of this work provide novel insights into the mechanisms of H2S-mediated protection against Hcy neurotoxicity. As Hcy is an independent risk factor for AD10,11,12,13,14 and ER stress is a crucial process in the pathogenesis of AD15,16,17, our findings suggest that H2S has potential therapeutic value in the treatment of neurodegenerative diseases such as AD.

Author contribution

Xiao-qing TANG designed the research; Hai-jun WEI, Jin-hua XU, Man-hong LI, Ji-ping TANG, Chun-yan WANG, and Wei ZOU performed the research; Hai-jun WEI, Li WANG, Man-hong LI, and Ji-ping TANG analyzed the data; and Xiao-qing TANG and Ping ZHANG wrote the paper.

Acknowledgments

This study was supported by the National Natural Science Foundation of China (No 81202518, 81200985, and 81071005), the Natural Science Foundation of Hunan Province, China (No 11JJ3117, 12JJ9032), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of the People's Republic of China ([2011]508) and the construct program of the key discipline in the Hunan province.

References

  1. Prudova A, Bauman Z, Braun A, Vitvitsky V, Lu SC, Banerjee R. S-adenosylmethionine stabilizes cystathionine beta-synthase and modulates redox capacity. Proc Natl Acad Sci U S A. 2006;103:6489–94. doi: 10.1073/pnas.0509531103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Selhub J. Homocysteine metabolism. Annu Rev Nutr. 1999;19:217–46. doi: 10.1146/annurev.nutr.19.1.217. [DOI] [PubMed] [Google Scholar]
  3. Kim JH, Cho SY, Lee JH, Jeong SM, Yoon IS, Lee BH, et al. Neuroprotective effects of ginsenoside Rg3 against homocysteine-induced excitotoxicity in rat hippocampus. Brain Res. 2007;1136:190–9. doi: 10.1016/j.brainres.2006.12.047. [DOI] [PubMed] [Google Scholar]
  4. Loureiro SO, Heimfarth L, Pelaez Pde L, Vanzin CS, Viana L, Wyse AT, et al. Homocysteine activates calcium-mediated cell signaling mechanisms targeting the cytoskeleton in rat hippocampus. Int J Dev Neurosci. 2008;26:447–55. doi: 10.1016/j.ijdevneu.2008.03.001. [DOI] [PubMed] [Google Scholar]
  5. Ho YS, Yu MS, Yang XF, So KF, Yuen WH, Chang RC. Neuroprotective effects of polysaccharides from wolfberry, the fruits of Lycium barbarum, against homocysteine-induced toxicity in rat cortical neurons. J Alzheimers Dis. 2010;19:813–27. doi: 10.3233/JAD-2010-1280. [DOI] [PubMed] [Google Scholar]
  6. Oldreive CE, Doherty GH. Neurotoxic effects of homocysteine on cerebellar Purkinje neurons in vitro. Neurosci Lett. 2007;413:52–7. doi: 10.1016/j.neulet.2006.11.031. [DOI] [PubMed] [Google Scholar]
  7. Kuszczyk M, Gordon-Krajcer W, Lazarewicz JW. Homocysteine-induced acute excitotoxicity in cerebellar granule cells in vitro is accompanied by PP2A-mediated dephosphorylation of tau. Neurochem Int. 2009;55:174–80. doi: 10.1016/j.neuint.2009.02.010. [DOI] [PubMed] [Google Scholar]
  8. Kim HJ, Cho HK, Kwon YH. Synergistic induction of ER stress by homocysteine and beta-amyloid in SH-SY5Y cells. J Nutr Biochem. 2008;19:754–61. doi: 10.1016/j.jnutbio.2007.09.009. [DOI] [PubMed] [Google Scholar]
  9. Park YJ, Jang Y, Kwon YH. Protective effect of isoflavones against homocysteine-mediated neuronal degeneration in SH-SY5Y cells. Amino Acids. 2010;39:785–94. doi: 10.1007/s00726-010-0523-5. [DOI] [PubMed] [Google Scholar]
  10. Van Dam F, Van Gool WA. Hyperhomocysteinemia and Alzheimer's disease: A systematic review. Arch Gerontol Geriatr. 2009;48:425–30. doi: 10.1016/j.archger.2008.03.009. [DOI] [PubMed] [Google Scholar]
  11. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346:476–83. doi: 10.1056/NEJMoa011613. [DOI] [PubMed] [Google Scholar]
  12. Miller JW. Homocysteine and Alzheimer's disease. Nutr Rev. 1999;57:126–9. doi: 10.1111/j.1753-4887.1999.tb06936.x. [DOI] [PubMed] [Google Scholar]
  13. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 1998;55:1449–55. doi: 10.1001/archneur.55.11.1449. [DOI] [PubMed] [Google Scholar]
  14. Dwyer BE, Raina AK, Perry G, Smith MA. Homocysteine and Alzheimer's disease: a modifiable risk. Free Radic Biol Med. 2004;36:1471–5. doi: 10.1016/j.freeradbiomed.2004.03.009. [DOI] [PubMed] [Google Scholar]
  15. Hoozemans JJ, Veerhuis R, Van Haastert ES, Rozemuller JM, Baas F, Eikelenboom P, et al. The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol. 2005;110:165–72. doi: 10.1007/s00401-005-1038-0. [DOI] [PubMed] [Google Scholar]
  16. Salminen A, Kauppinen A, Suuronen T, Kaarniranta K, Ojala J. ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology. J Neuroinflammation. 2009;6:41. doi: 10.1186/1742-2094-6-41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cornejo VH, Hetz C. The unfolded protein response in Alzheimer's disease. Semin Immunopathol. 2013;35:277–92. doi: 10.1007/s00281-013-0373-9. [DOI] [PubMed] [Google Scholar]
  18. Pizzo P, Pozzan T. Mitochondria-endoplasmic reticulum choreography: structure and signaling dynamics. Trends Cell Biol. 2007;17:511–7. doi: 10.1016/j.tcb.2007.07.011. [DOI] [PubMed] [Google Scholar]
  19. Kim I, Xu W, Reed JC. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov. 2008;7:1013–30. doi: 10.1038/nrd2755. [DOI] [PubMed] [Google Scholar]
  20. Schroder M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res. 2005;569:29–63. doi: 10.1016/j.mrfmmm.2004.06.056. [DOI] [PubMed] [Google Scholar]
  21. Wei H, Zhang R, Jin H, Liu D, Tang X, Tang C, et al. Hydrogen sulfide attenuates hyperhomocysteinemia-induced cardiomyocytic endoplasmic reticulum stress in rats. Antioxid Redox Signal. 2010;12:1079–91. doi: 10.1089/ars.2009.2898. [DOI] [PubMed] [Google Scholar]
  22. Outinen PA, Sood SK, Pfeifer SI, Pamidi S, Podor TJ, Li J, et al. Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood. 1999;94:959–67. [PubMed] [Google Scholar]
  23. Chigurupati S, Wei Z, Belal C, Vandermey M, Kyriazis GA, Arumugam TV, et al. The homocysteine-inducible endoplasmic reticulum stress protein counteracts calcium store depletion and induction of CCAAT enhancer-binding protein homologous protein in a neurotoxin model of Parkinson disease. J Biol Chem. 2009;284:18323–33. doi: 10.1074/jbc.M109.020891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Zhang C, Cai Y, Adachi MT, Oshiro S, Aso T, Kaufman RJ, et al. Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem. 2001;276:35867–74. doi: 10.1074/jbc.M100747200. [DOI] [PubMed] [Google Scholar]
  25. Yu X, Lv J, Zhu Y, Duan L, Ma L. Homocysteine inhibits hepatocyte proliferation via endoplasmic reticulum stress. PLoS One. 2013;8:e 54265. doi: 10.1371/journal.pone.0054265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kimura H. Hydrogen sulfide as a neuromodulator. Mol Neurobiol. 2002;26:13–9. doi: 10.1385/MN:26:1:013. [DOI] [PubMed] [Google Scholar]
  27. Kimura H, Shibuya N, Kimura Y. Hydrogen sulfide is a signaling molecule and a cytoprotectant. Antioxid Redox Signal. 2012;17:45–57. doi: 10.1089/ars.2011.4345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hu LF, Lu M, Hon Wong PT, Bian JS. Hydrogen sulfide: neurophysiology and neuropathology. Antioxid Redox Signal. 2011;15:405–19. doi: 10.1089/ars.2010.3517. [DOI] [PubMed] [Google Scholar]
  29. Zhou CF, Tang XQ. Hydrogen sulfide and nervous system regulation. Chin Med J (Engl) 2011;124:3576–82. [PubMed] [Google Scholar]
  30. Tang XQ, Shen XT, Huang YE, Chen RQ, Ren YK, Fang HR, et al. Inhibition of endogenous hydrogen sulfide generation is associated with homocysteine-induced neurotoxicity: role of ERK1/2 activation. J Mol Neurosci. 2011;45:60–7. doi: 10.1007/s12031-010-9477-z. [DOI] [PubMed] [Google Scholar]
  31. Tang XQ, Shen XT, Huang YE, Ren YK, Chen RQ, Hu B, et al. Hydrogen sulfide antagonizes homocysteine-induced neurotoxicity in PC12 cells. Neurosci Res. 2010;68:241–9. doi: 10.1016/j.neures.2010.07.2039. [DOI] [PubMed] [Google Scholar]
  32. Chen ZF, Zhao B, Tang XY, Li W, Zhu LL, Tang CS, et al. Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice. Chin Med J (Engl) 2011;124:3460–7. [PubMed] [Google Scholar]
  33. Wang XY, Yang CT, Zheng DD, Mo LQ, Lan AP, Yang ZL, et al. Hydrogen sulfide protects H9c2 cells against doxorubicin-induced cardiotoxicity through inhibition of endoplasmic reticulum stress. Mol Cell Biochem. 2012;363:419–26. doi: 10.1007/s11010-011-1194-6. [DOI] [PubMed] [Google Scholar]
  34. Xie L, Tiong CX, Bian JS. Hydrogen sulfide protects SH-SY5Y cells against 6-hydroxydopamine-induced endoplasmic reticulum stress. Am J Physiol Cell Physiol. 2012;303:C81–91. doi: 10.1152/ajpcell.00281.2011. [DOI] [PubMed] [Google Scholar]
  35. Chen G, Fan Z, Wang X, Ma C, Bower KA, Shi X, et al. Brain-derived neurotrophic factor suppresses tunicamycin-induced upregulation of CHOP in neurons. J Neurosci Res. 2007;85:1674–84. doi: 10.1002/jnr.21292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Shimoke K, Utsumi T, Kishi S, Nishimura M, Sasaya H, Kudo M, et al. Prevention of endoplasmic reticulum stress-induced cell death by brain-derived neurotrophic factor in cultured cerebral cortical neurons. Brain Res. 2004;1028:105–11. doi: 10.1016/j.brainres.2004.09.005. [DOI] [PubMed] [Google Scholar]
  37. Zhu W, Bijur GN, Styles NA, Li X. Regulation of FOXO3a by brain-derived neurotrophic factor in differentiated human SH-SY5Y neuroblastoma cells. Brain Res Mol Brain Res. 2004;126:45–56. doi: 10.1016/j.molbrainres.2004.03.019. [DOI] [PubMed] [Google Scholar]
  38. Li Y, Zhang H, Jiang C, Xu M, Pang Y, Feng J, et al. Hyperhomocysteinemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue. J Biol Chem. 2013;288:9583–92. doi: 10.1074/jbc.M112.431627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Park SJ, Kim KJ, Kim WU, Oh IH, Cho CS. Involvement of endoplasmic reticulum stress in homocysteine-induced apoptosis of osteoblastic cells. J Bone Miner Metab. 2012;30:474–84. doi: 10.1007/s00774-011-0346-9. [DOI] [PubMed] [Google Scholar]
  40. Zbidi H, Redondo PC, Lopez JJ, Bartegi A, Salido GM, Rosado JA. Homocysteine induces caspase activation by endoplasmic reticulum stress in platelets from type 2 diabetics and healthy donors. Thromb Haemost. 2010;103:1022–32. doi: 10.1160/TH09-08-0552. [DOI] [PubMed] [Google Scholar]
  41. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest. 2001;107:1263–73. doi: 10.1172/JCI11596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Stipanuk MH. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr. 2004;24:539–77. doi: 10.1146/annurev.nutr.24.012003.132418. [DOI] [PubMed] [Google Scholar]
  43. White AR, Huang X, Jobling MF, Barrow CJ, Beyreuther K, Masters CL, et al. Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways. J Neurochem. 2001;76:1509–20. doi: 10.1046/j.1471-4159.2001.00178.x. [DOI] [PubMed] [Google Scholar]
  44. Ho PI, Collins SC, Dhitavat S, Ortiz D, Ashline D, Rogers E, et al. Homocysteine potentiates beta-amyloid neurotoxicity: role of oxidative stress. J Neurochem. 2001;78:249–53. doi: 10.1046/j.1471-4159.2001.00384.x. [DOI] [PubMed] [Google Scholar]
  45. Kimura Y, Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 2004;18:1165–7. doi: 10.1096/fj.04-1815fje. [DOI] [PubMed] [Google Scholar]
  46. Tang XQ, Yang CT, Chen J, Yin WL, Tian SW, Hu B, et al. Effect of hydrogen sulphide on beta-amyloid-induced damage in PC12 cells. Clin Exp Pharmacol Physiol. 2008;35:180–6. doi: 10.1111/j.1440-1681.2007.04799.x. [DOI] [PubMed] [Google Scholar]
  47. Whiteman M, Armstrong JS, Chu SH, Jia-Ling S, Wong BS, Cheung NS, et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'. J Neurochem. 2004;90:765–8. doi: 10.1111/j.1471-4159.2004.02617.x. [DOI] [PubMed] [Google Scholar]
  48. Whiteman M, Cheung NS, Zhu YZ, Chu SH, Siau JL, Wong BS, et al. Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain. Biochem Biophys Res Commun. 2005;326:794–8. doi: 10.1016/j.bbrc.2004.11.110. [DOI] [PubMed] [Google Scholar]
  49. Eto K, Asada T, Arima K, Makifuchi T, Kimura H. Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun. 2002;293:1485–8. doi: 10.1016/S0006-291X(02)00422-9. [DOI] [PubMed] [Google Scholar]
  50. Tang XQ, Ren YK, Zhou CF, Yang CT, Gu HF, He JQ, et al. Hydrogen sulfide prevents formaldehyde-induced neurotoxicity to PC12 cells by attenuation of mitochondrial dysfunction and pro-apoptotic potential. Neurochem Int. 2012;61:16–24. doi: 10.1016/j.neuint.2012.04.011. [DOI] [PubMed] [Google Scholar]
  51. Hu LF, Lu M, Wu ZY, Wong PT, Bian JS. Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function. Mol Pharmacol. 2009;75:27–34. doi: 10.1124/mol.108.047985. [DOI] [PubMed] [Google Scholar]
  52. Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest. 2005;115:2656–64. doi: 10.1172/JCI26373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors. 2004;22:123–31. doi: 10.1080/08977190410001723308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677–736. doi: 10.1146/annurev.neuro.24.1.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Zuccato C, Cattaneo E. Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol. 2009;5:311–22. doi: 10.1038/nrneurol.2009.54. [DOI] [PubMed] [Google Scholar]
  56. Pezet S, Malcangio M. Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opin Ther Targets. 2004;8:391–9. doi: 10.1517/14728222.8.5.391. [DOI] [PubMed] [Google Scholar]

Articles from Acta Pharmacologica Sinica are provided here courtesy of Nature Publishing Group

RESOURCES